The consumer industry continues to be a hotbed of innovation, with activity driven by health and wellness, and convenience, and the growing importance of plant-based/alternative proteins, food safety and transparency, and, personalised nutrition. In the last three years alone, there have been over 450,000 patents filed and granted in the consumer industry, according to GlobalData’s report on Innovation in Consumer: Insulin stimulating foods.
However, not all innovations are equal and nor do they follow a constant upward trend. Instead, their evolution takes the form of an S-shaped curve that reflects their typical lifecycle from early emergence to accelerating adoption, before finally stabilising and reaching maturity.
Identifying where a particular innovation is on this journey, especially those that are in the emerging and accelerating stages, is essential for understanding their current level of adoption and the likely future trajectory and impact they will have.
40+ innovations will shape the consumer industry
According to GlobalData’s Technology Foresights, which plots the S-curve for the consumer industry using innovation intensity models built on over 110,000 patents, there are 40+ innovation areas that will shape the future of the industry.
Within the emerging innovation stage, hydrogel dressings, dextrin-based compositions, and safety injection needles are disruptive technologies that are in the early stages of application and should be tracked closely. Wet wipes dispenser, carbon fibre sports equipment, and cigarette rod making device are some of the accelerating innovation areas, where adoption has been steadily increasing. Among maturing innovation areas are portable toothbrush cases and anabolic muscle supplements, which are now well established in the industry.
Innovation S-curve for the consumer industry
Insulin-stimulating foods is a key innovation area in consumer
Insulin helps to balance the micronutrient level in the human body and thereby regulate the energy supply in the body.
Insulin-stimulating foods provide energy to the body so that the body can function properly.
GlobalData’s analysis also uncovers the companies at the forefront of each innovation area and assesses the potential reach and impact of their patenting activity across different applications and geographies. According to GlobalData, there are 20+ companies, spanning technology vendors, established consumer companies, and up-and-coming start-ups engaged in the development and application of insulin-stimulating foods.
Key players in insulin stimulating foods – a disruptive innovation in the consumer industry
‘Application diversity’ measures the number of different applications identified for each relevant patent and broadly splits companies into either ‘niche’ or ‘diversified’ innovators.
‘Geographic reach’ refers to the number of different countries each relevant patent is registered in and reflects the breadth of geographic application intended, ranging from ‘global’ to ‘local’.
Patent volumes related to insulin stimulating foods
|Company||Total patents (2010 - 2021)||Premium intelligence on the world's largest companies|
|Nestle||87||Unlock company profile|
|Danone||68||Unlock company profile|
|Sigrid Therapeutics||30||Unlock company profile|
|Morinaga Milk Industry||30||Unlock company profile|
|New World Pharmaceuticals||26||Unlock company profile|
|DuPont de Nemours||23||Unlock company profile|
|JDS Therapeutics||22||Unlock company profile|
|Suddeutsche Zuckerrubenverwertungs-Genossenschaft eG||20||Unlock company profile|
|NuSirt Biopharma||19||Unlock company profile|
|Rohto Pharmaceutical||18||Unlock company profile|
|SyneuRx International (Taiwan)||17||Unlock company profile|
|Chr. Hansen Holding||17||Unlock company profile|
|InovoBiologic||16||Unlock company profile|
|Biophytis||14||Unlock company profile|
|Boston Scientific||13||Unlock company profile|
|Ji Kwang||13||Unlock company profile|
|Medesis Pharma||12||Unlock company profile|
|BioGaia||11||Unlock company profile|
|Mcpharma Biotech||10||Unlock company profile|
|Micropharma||7||Unlock company profile|
|CJ CheilJedang||7||Unlock company profile|
|Mondelez International||6||Unlock company profile|
|Ajinomoto||6||Unlock company profile|
|Nu Skin Enterprises||5||Unlock company profile|
|TOKIWA Phytochemical||5||Unlock company profile|
Source: GlobalData Patent Analytics
Nestle is one of the leading patent filers in the insulin-stimulating foods space. Some other key patent filers in the space are Danone, Sigrid Therapeutics, and Morinaga Milk Industry. Recently, Danone India introduced Protinex Diabetes Care. The new product is aimed at addressing the nutritional needs of consumers with diabetes.
In terms of application diversity, New World Pharmaceuticals leads the pack, while DuPont de Nemours, and Biophytis stood in the second and third positions, respectively. By means of geographic reach, Suddeutsche Zuckerrubenverwertungs-Genossenschaft held the top position, followed by Ji Kwang and InovoBiologic.
Insulin-stimulating foods will potentially gain greater importance in the near future, with consumers increasingly becoming more health conscious. These foods will also find greater importance in the medical segment.
To further understand the key themes and technologies disrupting the consumer industry, access GlobalData’s latest thematic research report on Consumer.